News

System that prioritizes opioids over non-addictive alternatives needs fixing, says ophthalmologist and Kansas senator.
The Trump administration’s plan to address the opioid crisis focuses on preventing overdose deaths, but neglects the ...
How could a non-opioid painkiller improve the lives of people with chronic pain? What makes a non-opioid painkiller safer ...
The availability of suzetrigine may represent a critical step in addressing the nation’s pain management crisis. While ...
Proposed transaction will raise $50 million in equity capital and enhance a publicly traded biopharmaceutical company focused on launching ...
On 30 January 2025, the US Food and Drug Administration (FDA) approved the non-opioid medication suzetrigine (JOURNAVX), which was developed by Vertex Pharmaceuticals for moderate to severe acute ...
Pacira Biosciences leads in non-opioid pain relief with Exparel & upcoming knee osteoarthritis therapy. Click here to read my ...
More than one in three adults in the UK suffers from chronic pain — just under 28 million people, according to the National Institute for Health and Care Excellence (Nice). But until now, the ...